Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




New Drug Assay Technology Licensed

By HospiMedica staff writers
Posted on 06 Jun 2002
An exclusive license to a recently issued US patent for methods relating to the measurement of electrical waveforms of tissue or cells has been obtained by Tensor Biosciences (Irvine, CA, USA) from Matsushita Electric Industrial Co, Ltd. More...
(Osaka, Japan). Tensor will apply the new technology to the development of in vitro drug screening assays.

Tensor has combined computer science and multi-electrode neurophsyiology to develop more predictive technology for discovering neurotherapeutics. The company has various patents on methods for testing drugs on slices of living brain tissue. The technology described in the new patent relates to Tensor's advanced brain slice culture methods and their application to multisite electrophysiology. Applications could include drug candidate characterization, development of in vitro models of psychiatric and neurodegenerative disorders, and rapid on-site testing of chronic drug toxicities and side effects on networks of neurons, revealing lethal and nonlethal drug effects for up to three weeks.

"In close partnership with Matsushita and the University of California at Irvine, we have now pioneered a method for measuring long-term drug effects on living brain tissue,” said Dr. James Whitson, president and CEO of Tensor.




Related Links:
Tensor Biosciences

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Syringe Pump
SP50 Series
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.